Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/AZ-11713908> ?p ?o }
Showing triples 1 to 67 of
67
with 100 triples per page.
- AZ-11713908 abstract "AZ-11713908 is a drug developed by AstraZeneca which is a peripherally selective cannabinoid agonist, acting as a potent agonist at the CB1 receptor and a partial agonist at CB2. It has poor blood–brain barrier penetration, and so while it is an effective analgesic in animal tests, it produces only peripheral effects at low doses, with much weaker symptoms of central effects compared to other cannabinoid drugs such as WIN 55,212-2. A large number of related benzimidazole derived cannabinoid ligands are known.".
- AZ-11713908 casNumber "1309682-69-6".
- AZ-11713908 iupacName "N-(1-(cyclohexylmethyl)-2-((5-ethoxypyridin-2-yl)methyl)-1H-benzo[d]imidazol-5-yl)-N-methylthiophene-2-sulfonamide".
- AZ-11713908 thumbnail AZ-11713908_structure.png?width=300.
- AZ-11713908 wikiPageID "33266942".
- AZ-11713908 wikiPageLength "4045".
- AZ-11713908 wikiPageOutDegree "15".
- AZ-11713908 wikiPageRevisionID "590724305".
- AZ-11713908 wikiPageWikiLink AM-6545.
- AZ-11713908 wikiPageWikiLink Agonist.
- AZ-11713908 wikiPageWikiLink Analgesic.
- AZ-11713908 wikiPageWikiLink AstraZeneca.
- AZ-11713908 wikiPageWikiLink Benzimidazole.
- AZ-11713908 wikiPageWikiLink Blood–brain_barrier.
- AZ-11713908 wikiPageWikiLink CB-13.
- AZ-11713908 wikiPageWikiLink Cannabinoid.
- AZ-11713908 wikiPageWikiLink Cannabinoid_receptor_type_1.
- AZ-11713908 wikiPageWikiLink Cannabinoid_receptor_type_2.
- AZ-11713908 wikiPageWikiLink Category:Benzimidazoles.
- AZ-11713908 wikiPageWikiLink Category:Cannabinoids.
- AZ-11713908 wikiPageWikiLink Partial_agonist.
- AZ-11713908 wikiPageWikiLink WIN_55,212-2.
- AZ-11713908 wikiPageWikiLinkText "AZ-11713908".
- AZ-11713908 c "27".
- AZ-11713908 casNumber "1309682".
- AZ-11713908 chemspiderid "26286889".
- AZ-11713908 h "32".
- AZ-11713908 hasPhotoCollection AZ-11713908.
- AZ-11713908 inchi "1".
- AZ-11713908 inchikey "YIEVWZCZMDYKQH-UHFFFAOYAA".
- AZ-11713908 iupacName "N--N-methylthiophene-2-sulfonamide".
- AZ-11713908 molecularWeight "524.697".
- AZ-11713908 n "4".
- AZ-11713908 o "3".
- AZ-11713908 s "2".
- AZ-11713908 smiles "c5ccsc5SNc3ccc1cncn1CC4CCCCC4".
- AZ-11713908 stdinchi "1".
- AZ-11713908 stdinchikey "YIEVWZCZMDYKQH-UHFFFAOYSA-N".
- AZ-11713908 verifiedfields "changed".
- AZ-11713908 width "240".
- AZ-11713908 wikiPageUsesTemplate Template:Cannabinoid-stub.
- AZ-11713908 wikiPageUsesTemplate Template:Cannabinoids.
- AZ-11713908 wikiPageUsesTemplate Template:Drugbox.
- AZ-11713908 subject Category:Benzimidazoles.
- AZ-11713908 subject Category:Cannabinoids.
- AZ-11713908 hypernym Drug.
- AZ-11713908 type Article.
- AZ-11713908 type ChemicalSubstance.
- AZ-11713908 type Drug.
- AZ-11713908 type Article.
- AZ-11713908 type Cannabinoid.
- AZ-11713908 type Chemical.
- AZ-11713908 type Drug.
- AZ-11713908 type Heterocycle.
- AZ-11713908 type ChemicalObject.
- AZ-11713908 type Thing.
- AZ-11713908 type Q8386.
- AZ-11713908 comment "AZ-11713908 is a drug developed by AstraZeneca which is a peripherally selective cannabinoid agonist, acting as a potent agonist at the CB1 receptor and a partial agonist at CB2. It has poor blood–brain barrier penetration, and so while it is an effective analgesic in animal tests, it produces only peripheral effects at low doses, with much weaker symptoms of central effects compared to other cannabinoid drugs such as WIN 55,212-2.".
- AZ-11713908 label "AZ-11713908".
- AZ-11713908 sameAs m.0h7pz3b.
- AZ-11713908 sameAs AZ-11713908.
- AZ-11713908 sameAs AZ-11713908.
- AZ-11713908 sameAs Q4655227.
- AZ-11713908 sameAs Q4655227.
- AZ-11713908 wasDerivedFrom AZ-11713908?oldid=590724305.
- AZ-11713908 depiction AZ-11713908_structure.png.
- AZ-11713908 isPrimaryTopicOf AZ-11713908.